Detalhe da pesquisa
1.
Massively parallel dissection of RNA in RNA-protein interactions in vivo.
Nucleic Acids Res
; 52(10): e48, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726866
2.
Towards resolution of the intron retention paradox in breast cancer.
Breast Cancer Res
; 24(1): 100, 2022 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581993
3.
Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.
Cell Mol Life Sci
; 78(3): 1011-1027, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32458023
4.
The Fusion of CLEC12A and MIR223HG Arises from a trans-Splicing Event in Normal and Transformed Human Cells.
Int J Mol Sci
; 22(22)2021 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830054
5.
Combining serum microRNA and CA-125 as prognostic indicators of preoperative surgical outcome in women with high-grade serous ovarian cancer.
Gynecol Oncol
; 148(1): 181-188, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132874
6.
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy.
Clin Cancer Res
; 29(10): 1969-1983, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795892
7.
Widespread Aberrant Alternative Splicing despite Molecular Remission in Chronic Myeloid Leukaemia Patients.
Cancers (Basel)
; 12(12)2020 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33322625
8.
Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1.
Front Cell Dev Biol
; 8: 552, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766238
9.
The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
Cells
; 8(8)2019 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430887
10.
Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs.
PLoS One
; 11(4): e0153200, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27054342
11.
Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets.
Front Oncol
; 4: 144, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24971229